Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Bailén, Rebeca  [Clear All Filters]
2024
Lahmer T, Salmanton-García J, Marchesi F, El-Ashwah S, Nucci M, Besson C, Itri F, Jaksic O, Čolović N, Weinbergerova B, et al. Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. Infection. 2024.
Salgado M, Gálvez C, Nijhuis M, Kwon M, E Cardozo-Ojeda F, Badiola J, Gorman MJ, Huyveneers LEP, Urrea V, Bandera A, et al. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study. Lancet HIV. 2024;11(6):e389-e405.
Lahmer T, Salmanton-García J, Marchesi F, El-Ashwah S, Nucci M, Besson C, Itri F, Jaksic O, Čolović N, Weinbergerova B, et al. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. Infection. 2024.
2023
Gómez-Centurión I, Rojas RMaria Mart, Bailén R, Muñoz C, Sabell S, Oarbeascoa G, Fernández-Caldas P, Carbonell D, Gayoso J, Martinez-Laperche C, et al. Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide. Ann Hematol. 2023.
2022
Bailén R, Pascual-Cascón MJesús, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, et al. Post-transplant cyclophosphamide after HLA identical compared to Haploidentical donor transplant in Acute Myeloid Leukemia: a study on behalf of GETH-TC. Transplant Cell Ther. 2022.
Vallejo M, Muñiz P, Kwon M, Solán L, Bailén R, Carbonell D, Chicano M, Suárez-González J, Catalán P, Bellón JMaría, et al. Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms. Ann Hematol. 2022.
2020
Kwon M, Bailén R, Díez-Martín JLuis. Evolution of the role of haploidentical stem cell transplantation: past, present, and future. Expert Rev Hematol. 2020:1-16.
Piñana JLuis, Martino R, García-García I, Parody R, Morales MDolores, Benzo G, Gómez-Catalan I, Coll R, De La Fuente I, Luna A, et al. Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol. 2020;9:21.
2019
Bailén R, Pérez-Corral AMaría, Pascual C, Kwon M, Serrano D, Gayoso J, Balsalobre P, Muñoz C, Díez-Martín JLuis, Anguita J. Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center. J Clin Apher. 2019.
Kwon M, Bailén R, Pascual-Cascón MJesús, Gallardo-Morillo AIsabel, Sola AGarcía, Balsalobre P, Solán L, Dorado N, Muñoz C, Serrano D, et al. Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation. Blood Adv. 2019;3(21):3351-3359.
Oarbeascoa G, Dorado N, Bailén R, Serrano D, Balsalobre P, Pradillo V, Guinea J, Padilla B, Sancho M, Machado M, et al. Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation. Chemotherapy. 2019:1-5.